Latest News & Features
Refine Search
Americas
Glenmark Generics has been granted approval to market a generic version of AstraZeneca’s ulcer treatment drug Prilosec (omeprazole delayed release capsules). 7 November 2014
Biotechnology
Law firm Eversheds has expanded its IP practice in Belgium with the addition of a new life sciences partner. 6 November 2014
Americas
Healthcare company Theranos has sued medical equipment supplier Becton, Dickinson, seeking a judgment of non-infringement over a disputed trademark. 6 November 2014
Americas
A Canadian children’s hospital has launched a lawsuit focusing on whether genes should be patentable; the first of its kind in the country. 6 November 2014
Biotechnology
Earlier this year, the Advocate General of
the CJEU opined that stem cells from parthenotes are patentable. Franz-Josef Zimmer and Markus Grammel examine the reasoning behind his opinion. 4 November 2014
Big Pharma
Depositing a microorganism in a country may be crucial for obtaining a method patent in that jurisdiction, but can come with its pitfalls, says Peter ten Haaft. 4 November 2014
Americas
Protecting rights related to desirable plant species is a delicate process, says Gabriel Di Blasi. 4 November 2014
Americas
US-based law firm Ropes & Gray has promoted two to partner roles in its life science practice in New York. 4 November 2014
Americas
A case that was expected to act as a benchmark for future patent cases in Canada has been settled a day before the country’s Supreme Court was due to hear arguments. 4 November 2014
Europe
Richard Bassett and Richard Wells look at what EU-based companies must consider in order to comply with the Nagoya Protocol, the regulation aimed at curbing biopiracy. 3 November 2014